Indirect presentation of mismatched human leukocyte antigen ‐B associates with outcomes of cord blood transplantation
Open Access
- 10 March 2025
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 206 (5) , 1406-1417
Abstract
Summary: Cord blood transplantation (CBT) is a valuable donor source for patients without human leukocyte antigen (HLA)‐matched donors. While CBT has a lower risk of graft‐versus‐host disease and requires less stringent histocompatibility, it is associated with a higher transplantation‐related mortality (TRM) compared to other donor sources. We hypothesized that assessing the immunogenicity of mismatched HLA could reveal non‐permissive mismatches contributing to increased TRM. We retrospectively analysed 1498 single‐unit CBT cases from 2000 to 2018 across eight Japanese institutions, evaluating the immunogenicity of mismatched HLA using the PIRCHE algorithm to examine binding affinities of HLA‐derived epitopes to donor or recipient HLA. Results indicated that Class I epitopes from mismatched recipient HLA‐B were significantly associated with poor outcomes due to higher TRM and lower neutrophil engraftment, particularly when presented on matched HLA class I. Notably, epitopes from HLA‐B exon 1 showed stronger prognostic significance, with HLA‐B alleles carrying M‐type leader peptides exhibiting higher affinity for these epitopes. Patients with a matched M‐type HLA‐B and Class I epitopes derived from mismatched HLA‐B exon 1 had worse outcomes. These findings suggest that immunogenicity‐informed donor selection could improve CBT outcomes.Keywords
Funding Information
- Leukemia and Lymphoma Society
This publication has 60 references indexed in Scilit:
- Umbilical cord blood: The promise and the uncertaintyStem Cells Translational Medicine, 2020
- Donor selection in a pediatric stem cell transplantation cohort using PIRCHE and HLA‐DPB1 typingPediatric Blood & Cancer, 2019
- Class II Human Leukocyte Antigen Epitope Mismatch Predicts De Novo Donor‐Specific Antibody Formation After Liver TransplantationLiver Transplantation, 2018
- Recommendations for Donor Human Leukocyte Antigen Assessment and Matching for Allogeneic Stem Cell Transplantation: Consensus Opinion of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN)Transplantation and Cellular Therapy, 2015
- Refinement of the Definition of Permissible HLA-DPB1 Mismatches with Predicted Indirectly ReCognizable HLA-DPB1 EpitopesTransplantation and Cellular Therapy, 2014
- Anti-HLA Antibodies Other than Against HLA-A, -B, -DRB1 Adversely Affect Engraftment and Nonrelapse Mortality in HLA-Mismatched Single Cord Blood Transplantation: Possible Implications of Unrecognized Donor-specific AntibodiesTransplantation and Cellular Therapy, 2014
- Scoring HLA Class I Mismatches by HistoCheck Does Not Predict Clinical Outcome in Unrelated Hematopoietic Stem Cell TransplantationTransplantation and Cellular Therapy, 2012
- Cord Blood Transplantation from Unrelated Donors in Adults with High-Risk Acute Myeloid LeukemiaTransplantation and Cellular Therapy, 2010
- Defining the Intensity of Conditioning Regimens: Working DefinitionsTransplantation and Cellular Therapy, 2009
- Umbilical Cord Blood Transplantation after Reduced-Intensity Conditioning for Elderly Patients with Hematologic DiseasesTransplantation and Cellular Therapy, 2008